Purity, ID & Quantitation
View the analytical report assigned to this product option.
View COA↗Imagine First
KLOW
KLOW
Regular price
$149.00
Regular price
Sale price
$149.00
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
KLOW is an 80 mg multi-peptide research blend designed for controlled laboratory investigation of complementary cellular and tissue-response pathways. Each vial is clearly labeled for straightforward identification and study planning.
Order individual vials. Lab Mix savings apply automatically in your cart as you add eligible vials. Product-specific analytical documentation can be viewed through the COA section when available.
For laboratory research use only.
Documentation
Certificate of Analysis
Select a product option to view its available documentation.
Endotoxin
View the endotoxin report assigned to this product option.
View COA↗Documentation applies only to the product option and lot identified in each report.
Research overview
Four components. Distinct research profiles.
KLOW combines four separately studied peptides in one lyophilized formulation. Evidence for individual components does not by itself establish the behavior of the combined blend.
GHK-CuCopper-binding tripeptide studied in extracellular-matrix and cellular-remodeling models.
BPC-15715-amino-acid peptide examined primarily in preclinical tissue-response research.
TB-500Thymosin beta-4-related peptide studied in actin regulation and cellular migration.
KPVLys-Pro-Val tripeptide studied in inflammatory-signaling and transport models.
Blend size80MG
ComponentsFour peptides
Research classMulti-pathway blend
Material formLyophilized powder
Compound Profile & Technical Overview
KLOW is an 80MG lyophilized research blend composed of GHK-Cu, BPC-157, TB-500, and KPV. GHK-Cu is a copper-binding tripeptide; BPC-157 is a 15-amino-acid peptide; TB-500 is a thymosin beta-4-related research peptide; and KPV is the Lys-Pro-Val tripeptide derived from the C-terminal region of alpha-MSH. The formulation brings these four compounds together for controlled multi-pathway investigation. Research on any individual ingredient should not be treated as proof of the combined blend's activity. The current-batch Purity, ID & Quantitation report documents the complete 80MG formulation.
Storage requirements
Protect from lightKeep refrigerated after reconstitutionAvoid freeze/thaw cycles
Lyophilized powder-20°CStated stability: 24+ months
Reconstituted solution2-8°CStated stability: approximately 30 days
Sealed lyophilized vials are described as heat-stable; refrigeration or freezing of sealed vials is optional. The 2-8°C guidance applies after reconstitution. Always follow the lot-specific documentation when it differs.
Published Research & References
Selected component references include KPV transport and inflammatory-signaling research, GHK-Cu regenerative and gene-expression review, and thymosin beta-4 cardiac-repair research. Evidence primarily concerns individual components, not the complete KLOW blend.
Important research notice
This material is offered strictly for laboratory research use. It is not intended for human or veterinary use, food use, compounding, diagnosis, treatment, cure, or prevention of disease. Component literature is provided as educational context and does not establish outcomes for the combined KLOW formulation.
FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · NOT A DRUG, FOOD, COSMETIC, OR MEDICAL PRODUCT